SCIENTURE HOLDINGS, INC. Gain (Loss) on Extinguishment of Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Gain (Loss) on Extinguishment of Debt of -$178.50 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2021-03-29
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-09-30 was -$7.44K.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2018-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for the quarter ending 2017-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2019 was -$178.50K.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2018 was -$7.44K.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2017 was -$16.56K.
- SCIENTURE HOLDINGS, INC. gain (loss) on extinguishment of debt for fiscal 2016 was -$37.58K.
| Period end | Gain (Loss) on Extinguishment of Debt 0 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 6 month as first filed | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | -$178.50K 10-K · filed 2021-03-29 | |||||||
| 2019-10-31 | $76.50K 10-K · filed 2021-03-29 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$7.44K derived: sum of 2 quarters · filed 2020-03-30 | -$7.44K derived: sum of 3 quarters · filed 2020-03-30 | -$7.44K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$7.44K 10-Q · filed 2019-10-28 | -$7.44K derived: sum of 2 quarters · filed 2019-10-28 | -$7.44K 10-Q · filed 2019-10-28 | |||||
| 2018-06-30 | $0.00 10-Q · filed 2018-07-27 | $0.00 10-Q · filed 2018-07-27 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$5.04K derived: sum of 2 quarters · filed 2019-03-22 | -$16.56K derived: sum of 3 quarters · filed 2019-03-22 | -$16.56K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$5.04K 10-Q · filed 2018-10-26 | -$16.56K derived: sum of 2 quarters · filed 2018-10-26 | -$16.56K 10-Q · filed 2018-10-26 | |||||
| 2017-06-30 | -$11.51K 10-Q · filed 2018-07-27 | -$11.51K 10-Q · filed 2018-07-27 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | -$37.58K 10-K · filed 2018-03-02 | $37.58K 10-K · filed 2017-03-30 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$37.58K 10-Q · filed 2017-11-07 | $37.58K 10-Q · filed 2016-11-14 | |||||
| 2016-06-30 | -$37.58K 10-Q · filed 2017-08-04 | $37.58K 10-Q · filed 2016-08-05 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $0.00 10-K · filed 2017-03-30 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-02 | $0.00 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-05 | |||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-02 | $576.42K 10-Q · filed 2015-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |